EBITDA: Income before interest, taxes, depreciation and amortization.
BetterLife Pharma Inc. (BETRF) had EBITDA of $-1.16M for the most recently reported fiscal year, ending 2026-01-31.
| Income Statement Financials | |
-- |
|
$-1.07M |
|
-- |
|
-- |
|
$1.16M |
|
$-1.16M |
|
$0.07M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.09M |
|
$-1.16M |
|
|
EBITDA |
$-1.16M |
145.88M |
|
145.88M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.16M |
|
-- |
|
-- |
|
$0.16M |
|
$4.80M |
|
$0.02M |
|
$0.02M |
|
$4.82M |
|
$-4.66M |
|
$-4.66M |
|
$-4.66M |
|
151.90M |
|
| Cash Flow Statement Financials | |
$-0.45M |
|
-- |
|
$0.45M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-0.00 |
|
-0.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
23.32% |
|
23.32% |
|
-687.99% |
|
23.42% |
|
$-0.03 |
|
$-0.00 |
|
$-0.00 |
|